Predictive Parameters of CyberKnife Fiducial-less (XSight Lung) Applicability for Treatment of Early Non-Small Cell Lung Cancer: A Single-Center Experience
- 16 August 2013
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 87 (3), 583-589
- https://doi.org/10.1016/j.ijrobp.2013.06.2048
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Motion Management and Image Guidance for Thoracic Tumor Radiotherapy: Clinical Treatment ProgramsPublished by S. Karger AG ,2011
- The CyberKnife in Clinical Use: Current Roles, Future ExpectationsPublished by S. Karger AG ,2011
- Radiothérapie stéréotaxique de carcinomes bronchiques primitifs : suivi non invasif de la cible en temps réelCancer/Radiothérapie, 2010
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJama-Journal Of The American Medical Association, 2010
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: Clinical outcomeRadiotherapy and Oncology, 2009
- Stereotactic radiosurgery for the treatment of stage I non–small cell lung cancer in high-risk patientsThe Journal of Thoracic and Cardiovascular Surgery, 2009
- CyberKnife® Radiosurgery for Stage I Lung Cancer: Results at 36 MonthsClinical Lung Cancer, 2007
- Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trialThe Annals of Thoracic Surgery, 2003